MIMETAS BV (Leiden, The Netherlands) develops organ-on-a-chip tissue models for evaluating drugs, chemicals and food components. Its unique microfluidic technology, designated OrganoPlate™, enables testing of compounds in high-throughput on miniaturized organ models. These models show better predictivity as compared to laboratory animals and conventional cell culture models. The OrganoPlate™ platform supports 3D cell culture under continuous perfusion and membrane-free co-culture, including epithelial and endothelial boundary tissues. MIMETAS offers OrganoPlates™, develops and validates customised disease, toxicology and transport models and will ultimately make her technology available for personalised therapy selection.
Contact Details
MIMETAS – The Organ-on-a-Chip Company
email info@mimetas.com
phone +31 85 888 3161
Address: J.H. Oortweg 19, 2333CH Leiden, The Netherlands
twitter @MIMETAS_3D
OrganoPlates™ serve as a highly useable platform for 3D cell cultures, are completely compatible with existing lab equipment, and can be used to develop true ‘organ-on-a-chip’ models. Co-founders of the…
See our Cookie Privacy Policy Here
